계정 가입
email 로 로그인
email 로 가입
수신함을 확인하세요
Kaleido BioSciences
About
Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $101M
- Industries
- Biotechnology
- Founded date
- Jan 1, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Kaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to leveraging the potential of the microbiome organ to treat disease and improve human health. The Company has built a human-centric proprietary product platform to enable the rapid and cost-efficient discovery and development of novel Microbiome Metabolic Therapies (MMT™). MMTs are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ’s existing microbes. Kaleido is advancing a broad pipeline of MMT candidates with the potential to address a variety of diseases and conditions with significant unmet patient needs.
Funding Rounds
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 26, 2018 | Series C | $101M | 1 | — | — | Detail |
Investors
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Abu Dhabi Investment Authority
|
— | Series C |
